PUBLISHER: KBV Research | PRODUCT CODE: 1093019
PUBLISHER: KBV Research | PRODUCT CODE: 1093019
Europe Preimplantation Genetics Diagnosis (PGD) Market Size, Share & Industry Trends Analysis Report By Test Type (Aneuploidy, Chromosomal Abnormalities, X-linked diseases), By Country and Growth Forecast, 2022 - 2028
The Europe Preimplantation Genetics Diagnosis (PGD) Market would witness market growth of 9.0% CAGR during the forecast period (2022-2028).
Preimplantation genetic testing is gaining popularity as a reproductive treatment option among persons with sex-linked genetic illnesses, single-gene donors, people with chromosomal problems, older women looking for a baby, and women who have had many abortions. The government has strict regulations that have a considerable impact on the market. PGD is primarily used to prevent genetic diseases by selecting just those embryos that do not have a known genetic problem. PGD can also be used to increase the chances of a successful pregnancy, match a sibling's HLA type to be a donor, reduce cancer risk, and sex selection. Preimplantation genetic diagnosis also allows for prenatal sex determination prior to implantation, which is referred to as preimplantation sex determination.
Some of the growth catalysts for the market are an increase in the occurrence of chronic diseases and impairments around the world. Because of the increased prevalence of genetic problems among children and difficulties among the elderly, preimplantation genetic testing is becoming highly popular. According to a survey conducted by Genetic Alliance, one out of every 25 children in the United Kingdom is impacted by a genetic abnormality, with approximately 30,000 babies diagnosed each year. Aside from that, over 500 million people and children in the country suffer from a hereditary illness.
Despite the fact that PGD is now a well-established treatment in several European nations, there is no current, complete independent data on PGD practice and provision in Europe. Patients and/or samples are frequently referred abroad as a result of differences in regulation, legislation, and technical infrastructure between European countries, but data on the extent and type of international movement, as well as access to PGD across Europe, is limited. The importance of complete quality assurance in assisted reproduction clinics, laboratories, and treatment methods has been emphasized, with the idea that European providers should have a formal quality system.
Pre-implantation genetic diagnostics for monogenic or single-gene disorders (PGT-M) can also be used to avert more than 600 genetic problems, according to the UK's Human Fertilization and Embryology Authority. One of the prominent trends in the regional market is a significant number of late pregnancy instances, which has resulted in a larger adoption of IVF techniques.
The Germany market dominated the Europe Preimplantation Genetics Diagnosis (PGD) Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $10,313 Thousands by 2028. The UK market is anticipated to grow at a CAGR of 8.2% during (2022 - 2028). Additionally, The France market would experience a CAGR of 9.8% during (2022 - 2028).
Based on Test Type, the market is segmented into Aneuploidy, Chromosomal Abnormalities, X-linked diseases, Single Gene Disorders, HLA Typing, Gender selection, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Illumina, Inc., Invitae Corporation, Natera, Inc., Agilent Technologies, Inc., PerkinElmer, Inc., Quest Diagnostics Incorporated, Reproductive Genetic Innovations, PacGenomics, CeGaT GmbH, and Laboratory Corporation of America Holdings.
Scope of the Study
Market Segments covered in the Report:
By Test Type
- Aneuploidy
- Chromosomal Abnormalities
- X-linked diseases
- Single Gene Disorders
- HLA Typing
- Gender selection
- Others
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Companies Profiled
- Illumina, Inc.
- Invitae Corporation
- Natera, Inc.
- Agilent Technologies, Inc.
- PerkinElmer, Inc.
- Quest Diagnostics Incorporated
- Reproductive Genetic Innovations
- PacGenomics
- CeGaT GmbH
- Laboratory Corporation of America Holdings
Unique Offerings from KBV Research
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 Europe Preimplantation Genetics Diagnosis (PGD) Market, by Test Type
- 1.4.2 Europe Preimplantation Genetics Diagnosis (PGD) Market, by Country
- 1.5 Methodology for the research
Chapter 2. Market Overview
- 2.1 Introduction
- 2.1.1 Overview
- 2.1.1.1 Market Composition and Scenario
- 2.1.1 Overview
- 2.2 Key Factors Impacting the Market
- 2.2.1 Market Drivers
- 2.2.2 Market Restraints
Chapter 3. Europe Preimplantation Genetics Diagnosis (PGD) Market by Test Type
- 3.1 Europe Aneuploidy Market by Country
- 3.2 Europe Chromosomal Abnormalities Market by Country
- 3.3 Europe X-linked diseases Market by Country
- 3.4 Europe Single Gene Disorders Market by Country
- 3.5 Europe HLA Typing Market by Country
- 3.6 Europe Gender selection Market by Country
- 3.7 Europe Other Test Type Market by Country
Chapter 4. Europe Preimplantation Genetics Diagnosis (PGD) Market by Country
- 4.1 Germany Preimplantation Genetics Diagnosis (PGD) Market
- 4.1.1 Germany Preimplantation Genetics Diagnosis (PGD) Market by Test Type
- 4.2 UK Preimplantation Genetics Diagnosis (PGD) Market
- 4.2.1 UK Preimplantation Genetics Diagnosis (PGD) Market by Test Type
- 4.3 France Preimplantation Genetics Diagnosis (PGD) Market
- 4.3.1 France Preimplantation Genetics Diagnosis (PGD) Market by Test Type
- 4.4 Russia Preimplantation Genetics Diagnosis (PGD) Market
- 4.4.1 Russia Preimplantation Genetics Diagnosis (PGD) Market by Test Type
- 4.5 Spain Preimplantation Genetics Diagnosis (PGD) Market
- 4.5.1 Spain Preimplantation Genetics Diagnosis (PGD) Market by Test Type
- 4.6 Italy Preimplantation Genetics Diagnosis (PGD) Market
- 4.6.1 Italy Preimplantation Genetics Diagnosis (PGD) Market by Test Type
- 4.7 Rest of Europe Preimplantation Genetics Diagnosis (PGD) Market
- 4.7.1 Rest of Europe Preimplantation Genetics Diagnosis (PGD) Market by Test Type
Chapter 5. Company Profiles
- 5.1 Illumina, Inc.
- 5.1.1 Company Overview
- 5.1.2 Financial Analysis
- 5.1.3 Regional Analysis
- 5.1.4 Research & Development Expense
- 5.2 Invitae Corporation
- 5.2.1 Company Overview
- 5.2.2 Financial Analysis
- 5.2.3 Regional Analysis
- 5.2.4 Research & Development Expenses
- 5.3 Natera Inc.
- 5.3.1 Company Overview
- 5.3.2 Financial Analysis
- 5.3.3 Regional Analysis
- 5.3.4 Research & Development Expenses
- 5.4 Agilent Technologies, Inc.
- 5.4.1 Company Overview
- 5.4.2 Financial Analysis
- 5.4.3 Segmental and Regional Analysis
- 5.4.4 Research & Development Expense
- 5.4.5 Recent Strategies and Developments:
- 5.4.5.1 Approvals and Trials:
- 5.5 PerkinElmer, Inc.
- 5.5.1 Company Overview
- 5.5.2 Financial Analysis
- 5.5.3 Segmental and Regional Analysis
- 5.5.4 Research & Development Expense
- 5.5.5 Recent Strategies and Developments:
- 5.5.5.1 Product Launches and Product Expansions:
- 5.6 Quest Diagnostics Incorporated
- 5.6.1 Company Overview
- 5.6.2 Financial Analysis
- 5.6.3 Segmental Analysis
- 5.7 Reproductive Genetic Innovations
- 5.7.1 Company Overview
- 5.8 PacGenomics
- 5.8.1 Company Overview
- 5.9 CeGaT GmbH
- 5.9.1 Company Overview
- 5.10. Laboratory Corporation of America Holdings
- 5.10.1 Company Overview
- 5.10.2 Financial Analysis
- 5.10.3 Segmental and Regional Analysis
LIST OF TABLES
- TABLE 1 Europe Preimplantation Genetics Diagnosis (PGD) Market, 2018 - 2021, USD Thousands
- TABLE 2 Europe Preimplantation Genetics Diagnosis (PGD) Market, 2022 - 2028, USD Thousands
- TABLE 3 Europe Preimplantation Genetics Diagnosis (PGD) Market by Test Type, 2018 - 2021, USD Thousands
- TABLE 4 Europe Preimplantation Genetics Diagnosis (PGD) Market by Test Type, 2022 - 2028, USD Thousands
- TABLE 5 Europe Aneuploidy Market by Country, 2018 - 2021, USD Thousands
- TABLE 6 Europe Aneuploidy Market by Country, 2022 - 2028, USD Thousands
- TABLE 7 Europe Chromosomal Abnormalities Market by Country, 2018 - 2021, USD Thousands
- TABLE 8 Europe Chromosomal Abnormalities Market by Country, 2022 - 2028, USD Thousands
- TABLE 9 Europe X-linked diseases Market by Country, 2018 - 2021, USD Thousands
- TABLE 10 Europe X-linked diseases Market by Country, 2022 - 2028, USD Thousands
- TABLE 11 Europe Single Gene Disorders Market by Country, 2018 - 2021, USD Thousands
- TABLE 12 Europe Single Gene Disorders Market by Country, 2022 - 2028, USD Thousands
- TABLE 13 Europe HLA Typing Market by Country, 2018 - 2021, USD Thousands
- TABLE 14 Europe HLA Typing Market by Country, 2022 - 2028, USD Thousands
- TABLE 15 Europe Gender selection Market by Country, 2018 - 2021, USD Thousands
- TABLE 16 Europe Gender selection Market by Country, 2022 - 2028, USD Thousands
- TABLE 17 Europe Other Test Type Market by Country, 2018 - 2021, USD Thousands
- TABLE 18 Europe Other Test Type Market by Country, 2022 - 2028, USD Thousands
- TABLE 19 Europe Preimplantation Genetics Diagnosis (PGD) Market by Country, 2018 - 2021, USD Thousands
- TABLE 20 Europe Preimplantation Genetics Diagnosis (PGD) Market by Country, 2022 - 2028, USD Thousands
- TABLE 21 Germany Preimplantation Genetics Diagnosis (PGD) Market, 2018 - 2021, USD Thousands
- TABLE 22 Germany Preimplantation Genetics Diagnosis (PGD) Market, 2022 - 2028, USD Thousands
- TABLE 23 Germany Preimplantation Genetics Diagnosis (PGD) Market by Test Type, 2018 - 2021, USD Thousands
- TABLE 24 Germany Preimplantation Genetics Diagnosis (PGD) Market by Test Type, 2022 - 2028, USD Thousands
- TABLE 25 UK Preimplantation Genetics Diagnosis (PGD) Market, 2018 - 2021, USD Thousands
- TABLE 26 UK Preimplantation Genetics Diagnosis (PGD) Market, 2022 - 2028, USD Thousands
- TABLE 27 UK Preimplantation Genetics Diagnosis (PGD) Market by Test Type, 2018 - 2021, USD Thousands
- TABLE 28 UK Preimplantation Genetics Diagnosis (PGD) Market by Test Type, 2022 - 2028, USD Thousands
- TABLE 29 France Preimplantation Genetics Diagnosis (PGD) Market, 2018 - 2021, USD Thousands
- TABLE 30 France Preimplantation Genetics Diagnosis (PGD) Market, 2022 - 2028, USD Thousands
- TABLE 31 France Preimplantation Genetics Diagnosis (PGD) Market by Test Type, 2018 - 2021, USD Thousands
- TABLE 32 France Preimplantation Genetics Diagnosis (PGD) Market by Test Type, 2022 - 2028, USD Thousands
- TABLE 33 Russia Preimplantation Genetics Diagnosis (PGD) Market, 2018 - 2021, USD Thousands
- TABLE 34 Russia Preimplantation Genetics Diagnosis (PGD) Market, 2022 - 2028, USD Thousands
- TABLE 35 Russia Preimplantation Genetics Diagnosis (PGD) Market by Test Type, 2018 - 2021, USD Thousands
- TABLE 36 Russia Preimplantation Genetics Diagnosis (PGD) Market by Test Type, 2022 - 2028, USD Thousands
- TABLE 37 Spain Preimplantation Genetics Diagnosis (PGD) Market, 2018 - 2021, USD Thousands
- TABLE 38 Spain Preimplantation Genetics Diagnosis (PGD) Market, 2022 - 2028, USD Thousands
- TABLE 39 Spain Preimplantation Genetics Diagnosis (PGD) Market by Test Type, 2018 - 2021, USD Thousands
- TABLE 40 Spain Preimplantation Genetics Diagnosis (PGD) Market by Test Type, 2022 - 2028, USD Thousands
- TABLE 41 Italy Preimplantation Genetics Diagnosis (PGD) Market, 2018 - 2021, USD Thousands
- TABLE 42 Italy Preimplantation Genetics Diagnosis (PGD) Market, 2022 - 2028, USD Thousands
- TABLE 43 Italy Preimplantation Genetics Diagnosis (PGD) Market by Test Type, 2018 - 2021, USD Thousands
- TABLE 44 Italy Preimplantation Genetics Diagnosis (PGD) Market by Test Type, 2022 - 2028, USD Thousands
- TABLE 45 Rest of Europe Preimplantation Genetics Diagnosis (PGD) Market, 2018 - 2021, USD Thousands
- TABLE 46 Rest of Europe Preimplantation Genetics Diagnosis (PGD) Market, 2022 - 2028, USD Thousands
- TABLE 47 Rest of Europe Preimplantation Genetics Diagnosis (PGD) Market by Test Type, 2018 - 2021, USD Thousands
- TABLE 48 Rest of Europe Preimplantation Genetics Diagnosis (PGD) Market by Test Type, 2022 - 2028, USD Thousands
- TABLE 49 key information - Illumina, Inc.
- TABLE 50 Key Information - Invitae Corporation
- TABLE 51 Key Information - Natera Inc.
- TABLE 52 key Information - Agilent Technologies, Inc.
- TABLE 53 key Information - PerkinElmer, Inc.
- TABLE 54 Key information - Quest Diagnostics Incorporated
- TABLE 55 Key information - Reproductive Genetic Innovations
- TABLE 56 Key Information - PacGenomics
- TABLE 57 key information - CeGaT GmbH
- TABLE 58 Key Information - Laboratory Corporation of America holdings
List of Figures
- FIG 1 Methodology for the research
